Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1987 Jun;80(6):368–373. doi: 10.1177/014107688708000613

Graft-versus-host disease: a review.

A J Barrett
PMCID: PMC1290858  PMID: 3305944

Full text

PDF
368

Images in this article

368Figure 1.
on p.368
369Figure 3.
on p.369
369Figure 4.
on p.369
370Figure 5.
on p.370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., van Rood J. J. The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med. 1976 Oct 7;295(15):806–813. doi: 10.1056/NEJM197610072951504. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. J., Kendra J. R., Lucas C. F., Joss D. V., Joshi R., Pendharkar P., Hugh-Jones K. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):162–166. doi: 10.1136/bmj.285.6336.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bozdech M. J., Sondel P. M., Trigg M. E., Longo W., Kohler P. C., Flynn B., Billing R., Anderson S. A., Hank J. A., Hong R. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol. 1985 Dec;13(11):1201–1210. [PubMed] [Google Scholar]
  4. Deeg H. J., Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med. 1984;35:11–24. doi: 10.1146/annurev.me.35.020184.000303. [DOI] [PubMed] [Google Scholar]
  5. Filipovich A. H., McGlave P. B., Ramsay N. K., Goldstein G., Warkentin P. I., Kesey J. H. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet. 1982 Jun 5;1(8284):1266–1269. doi: 10.1016/s0140-6736(82)92840-9. [DOI] [PubMed] [Google Scholar]
  6. Gluckman E., Berger R., Dutreix J. Bone marrow transplantation for Fanconi anemia. Semin Hematol. 1984 Jan;21(1):20–26. [PubMed] [Google Scholar]
  7. Gluckman E., Devergie A., Sohier J., Saurat J. H. Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet. 1980 Feb 2;1(8162):253–254. [PubMed] [Google Scholar]
  8. Hale G., Bright S., Chumbley G., Hoang T., Metcalf D., Munro A. J., Waldmann H. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood. 1983 Oct;62(4):873–882. [PubMed] [Google Scholar]
  9. Jones J. M., Wilson R., Bealmear P. M. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res. 1971 Mar;45(3):577–588. [PubMed] [Google Scholar]
  10. Kay H., Lumley H., Clink H. M., Powles R. L. Ratio of blood and marrow-derived cells in bone marrow transplantation. J Clin Pathol. 1982 May;35(5):492–495. doi: 10.1136/jcp.35.5.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kendra J., Barrett A. J., Lucas C., Joshi R., Joss V., Desai M., Halil O., Rogers T. R., Hobbs J. R., Hugh-Jones K. Response of graft versus host disease to high doses of methyl prednisolone. Clin Lab Haematol. 1981;3(1):19–26. doi: 10.1111/j.1365-2257.1981.tb01305.x. [DOI] [PubMed] [Google Scholar]
  12. Lampert I. A., Janossy G., Suitters A. J., Bofill M., Palmer S., Gordon-Smith E., Prentice H. G., Thomas J. A. Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol. 1982 Oct;50(1):123–131. [PMC free article] [PubMed] [Google Scholar]
  13. McGOVERN J. J., Jr, RUSSELL P. S., ATKINS L., WEBSTER E. W. Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. N Engl J Med. 1959 Apr 2;260(14):675–683. doi: 10.1056/NEJM195904022601401. [DOI] [PubMed] [Google Scholar]
  14. Müller-Ruchholtz W., Müller-Hermelink H. K., Wottge H. U. Induction of lasting hemopoietic chimerism in a xenogeneic (rat to mouse) model. Transplant Proc. 1979 Mar;11(1):517–521. [PubMed] [Google Scholar]
  15. Powles R. L., Barrett A. J., Clink H., Kay H. E., Sloane J., McElwain T. J. Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet. 1978 Dec 23;2(8104-5):1327–1331. doi: 10.1016/s0140-6736(78)91971-2. [DOI] [PubMed] [Google Scholar]
  16. Prentice H. G., Blacklock H. A., Janossy G., Bradstock K. F., Skeggs D., Goldstein G., Hoffbrand A. V. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet. 1982 Mar 27;1(8274):700–703. doi: 10.1016/s0140-6736(82)92619-8. [DOI] [PubMed] [Google Scholar]
  17. Ramsay N. K., Kersey J. H., Robison L. L., McGlave P. B., Woods W. G., Krivit W., Kim T. H., Goldman A. I., Nesbit M. E., Jr A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med. 1982 Feb 18;306(7):392–397. doi: 10.1056/NEJM198202183060703. [DOI] [PubMed] [Google Scholar]
  18. Reisner Y., Kapoor N., Kirkpatrick D., Pollack M. S., Dupont B., Good R. A., O'Reilly R. J. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet. 1981 Aug 15;2(8242):327–331. doi: 10.1016/s0140-6736(81)90647-4. [DOI] [PubMed] [Google Scholar]
  19. Rodt H., Kolb H. J., Netzel B., Haas R. J., Wilms K., Götze C. B., Link H., Thierfelder S. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc. 1981 Mar;13(1 Pt 1):257–261. [PubMed] [Google Scholar]
  20. Seto F. Enlargement and immune activity of chick embryo host spleen associated with transfer of B-haplotype-matched donor lymphoid cells. Exp Hematol. 1984 Jan;12(1):53–59. [PubMed] [Google Scholar]
  21. Storb R., Epstein R. B., Graham T. C., Thomas E. D. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation. 1970 Mar;9(3):240–246. doi: 10.1097/00007890-197003000-00007. [DOI] [PubMed] [Google Scholar]
  22. Storb R., Prentice R. L., Buckner C. D., Clift R. A., Appelbaum F., Deeg J., Doney K., Hansen J. A., Mason M., Sanders J. E. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med. 1983 Feb 10;308(6):302–307. doi: 10.1056/NEJM198302103080602. [DOI] [PubMed] [Google Scholar]
  23. Storb R., Prentice R. L., Sullivan K. M., Shulman H. M., Deeg H. J., Doney K. C., Buckner C. D., Clift R. A., Witherspoon R. P., Appelbaum F. A. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med. 1983 Apr;98(4):461–466. doi: 10.7326/0003-4819-98-4-461. [DOI] [PubMed] [Google Scholar]
  24. Sullivan K. M., Shulman H. M., Storb R., Weiden P. L., Witherspoon R. P., McDonald G. B., Schubert M. M., Atkinson K., Thomas E. D. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981 Feb;57(2):267–276. [PubMed] [Google Scholar]
  25. THOMAS E. D., HERMAN E. C., Jr, GREENOUGH W. B., 3rd, HAGER E. B., CANNON J. H., SAHLER O. D., FERREBEE J. W. Irradiation and marrow infusion in leukemia. Observations in five patients with acute leukemia treated by whole-body exposures of 1,400 to 2,000 roentgens and infusions of marrow. Arch Intern Med. 1961 Jun;107:829–845. doi: 10.1001/archinte.1961.03620060029006. [DOI] [PubMed] [Google Scholar]
  26. THOMAS E. D., LOCHTE H. L., Jr, CANNON J. H., SAHLER O. D., FERREBEE J. W. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest. 1959 Oct;38:1709–1716. doi: 10.1172/JCI103949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Treleaven J. G., Gibson F. M., Ugelstad J., Rembaum A., Philip T., Caine G. D., Kemshead J. T. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet. 1984 Jan 14;1(8368):70–73. doi: 10.1016/s0140-6736(84)90004-7. [DOI] [PubMed] [Google Scholar]
  28. Trentin J. J., Judd K. P. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG). Transplant Proc. 1973 Mar;5(1):865–868. [PubMed] [Google Scholar]
  29. Witherspoon R. P., Lum L. G., Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol. 1984 Jan;21(1):2–10. [PubMed] [Google Scholar]
  30. de Witte T., Raymakers R., Plas A., Koekman E., Wessels H., Haanen C. Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation. 1984 Feb;37(2):151–155. doi: 10.1097/00007890-198402000-00007. [DOI] [PubMed] [Google Scholar]
  31. van Bekkum D. W., Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst. 1977 Mar;58(3):787–790. doi: 10.1093/jnci/58.3.787. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES